From Casetext: Smarter Legal Research

Aventis Pharma S.A. v. Strides, Inc.

United States Court of Appleas for the Federal Circuit
Feb 7, 2012
2012-1151 (Fed. Cir. Feb. 7, 2012)

Opinion

2012-1151

02-07-2012

AVENTIS PHARMA S.A. and SANOFI-AVENTIS U.S. LLC, Plaintiffs-Appellants, v. STRIDES, INC. and ONCO THERAPIES LIMITED, Defendants-Appellees.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in case no. ll-CV-1121, Chief Judge Gregory M. Sleet.

ON MOTION


ORDER

Aventis Pharma S.A. et al. move without opposition to stay proceedings in this case pending the court's disposition in Aventis Pharma SA. v. Hospira Inc., No. 2011-1018.

Aventis asserts that the appeals involve the same patents and that the consent judgment from which this appeal was taken was based upon the judgment in Hospira.

The court notes that oral argument was held in Hospira on January 9, 2012.

Accordingly,

IT IS ORDERED THAT:

(1) The motion is granted. The briefing schedule is stayed in 2012-1151. Aventis is directed to inform the court within 30 days of the disposition of Hospira how this appeal should proceed. The appellees may also respond within that time.

(2) A copy of this order shall be transmitted to the merits panel assigned to hear Hospira to inform that panel of this related case.

FOR THE COURT

Jan Horbaly

Clerk

cc: George F. Pappas, Esq.

Neal C. Belgam, Esq.

sl9


Summaries of

Aventis Pharma S.A. v. Strides, Inc.

United States Court of Appleas for the Federal Circuit
Feb 7, 2012
2012-1151 (Fed. Cir. Feb. 7, 2012)
Case details for

Aventis Pharma S.A. v. Strides, Inc.

Case Details

Full title:AVENTIS PHARMA S.A. and SANOFI-AVENTIS U.S. LLC, Plaintiffs-Appellants, v…

Court:United States Court of Appleas for the Federal Circuit

Date published: Feb 7, 2012

Citations

2012-1151 (Fed. Cir. Feb. 7, 2012)